BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8861998)

  • 1. The position of the heterologous domain can influence the solubility and proteolysis of beta-galactosidase fusion proteins in E. coli.
    Corchero JL; Viaplana E; Benito A; Villaverde A
    J Biotechnol; 1996 Jul; 48(3):191-200. PubMed ID: 8861998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uses of beta-galactosidase tag in on-line monitoring production of fusion proteins and gene expression in Escherichia coli.
    Benito A; Valero F; Lafuente J; Vidal M; Cairo J; Solà C; Villaverde A
    Enzyme Microb Technol; 1993 Jan; 15(1):66-71. PubMed ID: 7764038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the N-terminal hydrophobic sequence of hepatitis B virus surface antigen on the folding and assembly of hybrid beta-galactosidase in Escherichia coli.
    Lee SC; Choi YC; Yu MH
    Eur J Biochem; 1990 Jan; 187(2):417-24. PubMed ID: 2105218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ proteolytic digestion of inclusion body polypeptides occurs as a cascade process.
    Cubarsí R; Carrió MM; Villaverde A
    Biochem Biophys Res Commun; 2001 Mar; 282(2):436-41. PubMed ID: 11401478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertion of a 27 amino acid viral peptide in different zones of Escherichia coli beta-galactosidase: effects on the enzyme activity.
    Benito A; Villaverde A
    FEMS Microbiol Lett; 1994 Oct; 123(1-2):107-12. PubMed ID: 7988875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermo-inducible expression of a recombinant fusion protein by Escherichia coli lac repressor mutants.
    Yabuta M; Onai-Miura S; Ohsuye K
    J Biotechnol; 1995 Feb; 39(1):67-73. PubMed ID: 7766012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance of Escherichia coli beta-galactosidase C-terminus to different-sized fusions.
    Corchero JL; Villaverde A
    Biotechnol Bioeng; 1999 Sep; 64(6):644-9. PubMed ID: 10417212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus.
    Broekhuijsen MP; Blom T; van Rijn J; Pouwels PH; Klasen EA; Fasbender MJ; Enger-Valk BE
    Gene; 1986; 49(2):189-97. PubMed ID: 2436976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The production of human parvovirus capsid proteins in Escherichia coli and their potential as diagnostic antigens.
    Rayment FB; Crosdale E; Morris DJ; Pattison JR; Talbot P; Clare JJ
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2665-72. PubMed ID: 1701479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubility of proteins isolated from inclusion bodies is enhanced by fusion to maltose-binding protein or thioredoxin.
    Sachdev D; Chirgwin JM
    Protein Expr Purif; 1998 Feb; 12(1):122-32. PubMed ID: 9473466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A set of beta-galactosidase gene fusion cassettes demonstrates usefulness in expressing HIV-1 genes in Escherichia coli.
    Valverde V; Duplan H; Knibiehler M; Masson JM
    Plasmid; 1994 Jul; 32(1):32-40. PubMed ID: 7991670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the DNA-binding properties of the polyomavirus capsid protein VP1.
    Moreland RB; Montross L; Garcea RL
    J Virol; 1991 Mar; 65(3):1168-76. PubMed ID: 1847446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of the outer-capsid glycoprotein of the simian rotavirus SA11 in Escherichia coli.
    Arias CF; Ballado T; Plebañski M
    Gene; 1986; 47(2-3):211-9. PubMed ID: 3030891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the beta-galactosidase gene from Thermus sp. strain T2: expression in Escherichia coli and purification in a single step of an active fusion protein.
    Vian A; Carrascosa AV; García JL; Cortés E
    Appl Environ Microbiol; 1998 Jun; 64(6):2187-91. PubMed ID: 9603833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of fusion proteins containing antigenic determinants of foot-and-mouth disease virus.
    Broekhuijsen MP; Blom T; Kottenhagen M; Pouwels PH; Meloen RH; Barteling SJ; Enger-Valk BE
    Vaccine; 1986 Jun; 4(2):119-24. PubMed ID: 2425505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of in vivo protein aggregation: building inclusion bodies in recombinant bacteria.
    Carrió MM; Corchero JL; Villaverde A
    FEMS Microbiol Lett; 1998 Dec; 169(1):9-15. PubMed ID: 9851031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid maintenance in Escherichia coli recombinant cultures is dramatically, steadily, and specifically influenced by features of the encoded proteins.
    Corchero JL; Villaverde A
    Biotechnol Bioeng; 1998 Jun; 58(6):625-32. PubMed ID: 10099300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, expression, and purification of the His(6)-tagged thermostable beta-galactosidase from Pyrococcus woesei in Escherichia coli and some properties of the isolated enzyme.
    Daabrowski S; Sobiewska G; Maciuńska J; Synowiecki J; Kur J
    Protein Expr Purif; 2000 Jun; 19(1):107-12. PubMed ID: 10833397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of fusion proteins expressed by pEX3 and a truncated pEX3 derivative.
    Kocken CH; Scheer JM; Welling GW; Welling-Wester S
    FEBS Lett; 1988 Aug; 236(1):132-4. PubMed ID: 3136038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cell adhesion peptide from foot-and-mouth disease virus can direct cell targeted delivery of a functional enzyme.
    Villaverde A; Feliu JX; Arís A; Harbottle RP; Benito A; Coutelle C
    Biotechnol Bioeng; 1998 Aug; 59(3):294-301. PubMed ID: 10099340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.